{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:13:59Z","timestamp":1765728839019,"version":"3.40.5"},"reference-count":28,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,3]]},"DOI":"10.20945\/2359-3997000000498","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T13:38:22Z","timestamp":1654522702000},"source":"Crossref","is-referenced-by-count":3,"title":["The evaluation of pancreas \u03b2-cell autoantibodies in non-diabetic COVID-19 patients"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-2681","authenticated-orcid":false,"given":"Sanem","family":"Kayhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-7409","authenticated-orcid":false,"given":"Sema","family":"Hepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-0513","authenticated-orcid":false,"given":"Hatice Kozan","family":"Kalkisim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-0405","authenticated-orcid":false,"given":"Ibrahim Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-2968","authenticated-orcid":false,"given":"Fatma Aybala","family":"Altay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-9248","authenticated-orcid":false,"given":"Ali","family":"Yalcindag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"4","key":"key20220606093816_B1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3345\/cep.2020.00493","article-title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome\u2013coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)","volume":"63","author":"Park","year":"2020","unstructured":"Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome\u2013coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr. 2020;63(4):119-24.","journal-title":"Clin Exp Pediatr"},{"issue":"13","key":"key20220606093816_B2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1056\/NEJMc2001899","article-title":"Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China","volume":"382","author":"Hoehl","year":"2020","unstructured":"Hoehl S, Rabenau H, Berger A, Kortenbusch M, Cinatl J, Bojkova D, et al. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020;382(13):1278-80.","journal-title":"N Engl J Med"},{"issue":"3","key":"key20220606093816_B3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193-9.","journal-title":"Acta Diabetol"},{"issue":"2","key":"key20220606093816_B4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7.","journal-title":"J Pathol"},{"issue":"8","key":"key20220606093816_B5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/dom.14086","article-title":"The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan","volume":"22","author":"Zhang","year":"2020","unstructured":"Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020;22(8):1443-54.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"key20220606093816_B6","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25.","journal-title":"J Infect"},{"issue":"8","key":"key20220606093816_B7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00125-020-05164-x","article-title":"Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature","volume":"63","author":"Katulanda","year":"2020","unstructured":"Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63(8):1440-52.","journal-title":"Diabetologia"},{"issue":"10","key":"key20220606093816_B8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s42255-020-00281-8","article-title":"Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report","volume":"2","author":"Hollstein","year":"2020","unstructured":"Hollstein T, Schulte DM, Schulz J, Gl\u00fcck A, Ziegler AG, Bonifacio E, et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020;2(10):1021-4.","journal-title":"Nat Metab"},{"issue":"8","key":"key20220606093816_B9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2020.13445","article-title":"Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany","volume":"324","author":"Kamrath","year":"2020","unstructured":"Kamrath C, M\u00f6nkem\u00f6ller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA. 2020;324(8):801-4.","journal-title":"JAMA"},{"key":"key20220606093816_B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.nutr.24.012003.132159","article-title":"Defective glucose homeostasis during infection","volume":"25","author":"McGuinness","year":"2005","unstructured":"McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr. 2005;25:9-35.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"key20220606093816_B11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2016.02.023","article-title":"The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia","volume":"165","author":"Okin","year":"2016","unstructured":"Okin D, Medzhitov R. The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia. Cell. 2016;165(2):343-56.","journal-title":"Cell"},{"key":"key20220606093816_B12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2002.tb02943.x","article-title":"Viruses and diabetes","volume":"958","author":"Jaeckel","year":"2002","unstructured":"Jaeckel E, Manns M, Von Herrath M. Viruses and diabetes. Ann N Y Acad Sci. 2002;958:7-25.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"key20220606093816_B13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s15007-018-1580-4","article-title":"Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?","volume":"27","author":"Pusch","year":"2018","unstructured":"Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J. 2018;27(3):28-45.","journal-title":"Allergo J"},{"issue":"4","key":"key20220606093816_B14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamapediatrics.2021.5801","article-title":"Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic","volume":"176","author":"Gottesman","year":"2022","unstructured":"Gottesman BL, Yu J, Tanaka C, Longhurst CA, Kim JJ. Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic. JAMA Pediatr. 2022;176(4):414-5.","journal-title":"JAMA Pediatr"},{"key":"key20220606093816_B15","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-0969","article-title":"Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry","author":"Kamrath","year":"2022","unstructured":"Kamrath C, Rosenbauer J, Eckert AJ, Siedler K, Bartelt H, Klose D, et al. Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry. Diabetes Care. 2022:dc210969.","journal-title":"Diabetes Care"},{"issue":"7","key":"key20220606093816_B16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jmv.25766","article-title":"Coronavirus disease 2019: What we know?","volume":"92","author":"He","year":"2020","unstructured":"He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020;92(7):719-25.","journal-title":"J Med Virol"},{"issue":"12","key":"key20220606093816_B17","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, Hyperglycemia, and New-Onset Diabetes","volume":"44","author":"Khunti","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021;44(12):2645-55.","journal-title":"Diabetes Care"},{"issue":"3","key":"key20220606093816_B18","first-page":"149","article-title":"Viruses and type 1 diabetes: a new look at an old story","volume":"14","author":"Craig","year":"2013","unstructured":"Craig ME, Nair S, Stein H, Rawlinson WD. Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes. 2013;14(3):149-58.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"key20220606093816_B19","first-page":"432","article-title":"Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells","volume":"85","author":"Roivainen","year":"2000","unstructured":"Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab. 2000;85(1):432-40.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20220606093816_B20","doi-asserted-by":"crossref","first-page":"2128.e2","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection","volume":"18","author":"Liu","year":"2020","unstructured":"Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol. 2020;18(9):2128-30.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"key20220606093816_B21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40618-020-01276-8","article-title":"COVID-19 and the endocrine system: exploring the unexplored","volume":"43","author":"Pal","year":"2020","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-31.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"key20220606093816_B22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(20)30315-6","article-title":"COVID-19 and diabetes: a co-conspiracy?","volume":"8","author":"The Lancet Diabetes Endocrinology","year":"2020","unstructured":"The Lancet Diabetes Endocrinology. COVID-19 and diabetes: a co-conspiracy? Lancet Diabetes Endocrinol. 2020;8(10):801.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20220606093816_B23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","unstructured":"Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94(1):54-62.","journal-title":"J Med Virol"},{"issue":"2","key":"key20220606093816_B24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-021-02770-6","article-title":"SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease","volume":"73","author":"Murugan","year":"2021","unstructured":"Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease. Endocrine. 2021;73(2):243-54.","journal-title":"Endocrine"},{"issue":"7","key":"key20220606093816_B25","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","unstructured":"Gazzaruso C, Carlo Stella N, Mariani G, Nai C, Coppola A, Naldani D, et al. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol. 2020;39(7):2095-7.","journal-title":"Clin Rheumatol"},{"key":"key20220606093816_B26","article-title":"Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series","volume":"369","author":"Argenziano","year":"2020","unstructured":"Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996.","journal-title":"BMJ"},{"issue":"6","key":"key20220606093816_B27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","unstructured":"Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-50.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20220606093816_B28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000076","article-title":"Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study","volume":"3","author":"S\u00f8rgjerd","year":"2015","unstructured":"S\u00f8rgjerd EP, Thorsby PM, Torjesen PA, Skorpen F, Kval\u00f8y K, Grill V. Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study. BMJ Open Diabetes Res Care. 2015;3(1):e000076.","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T13:38:41Z","timestamp":1654522721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/the-evaluation-of-pancreas-%ce%b2-cell-autoantibodies-in-non-diabetic-covid-19-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":28,"alternative-id":["10.20945\/2359-3997000000498"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000498","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2022,6,3]]}}}